Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

30 results about "Colon polyps" patented technology

Fleshy growths on the inside the large intestine.

Method for the early detection of breast cancer, lung cancer, pancreatic cancer and colon polyps, growths and cancers as well as other gastrointestinal disease conditions and the preoperative and postoperative monitoring of transplanted organs from the donor and in the recipient and their associated conditions related and unrelated to the organ transplantation

A method for the early diagnosis of breast, lung, pancreatic and colon growths and cancers as well as conditions associated with donor and recipient organ transplants, both before and after transplantation to identify and allow treatment of possible transplanted organ rejection and other disease conditions related and unrelated to the transplantation, compares the gene expression patterns from a patient's peripheral blood monocytes-lymphocyte's gene system with either the similar gene expression patterns of a normal person, or with the similar gene expression patterns of a person known to have the condition being screened for. Differences between the patient's gene expression patterns for particular genes and the normal patterns indicates the presence of the condition with the number of differences indicating the probability of the condition. Similarities between the patient's gene expression patterns for those particular genes and the patterns of a person known to have the condition indicates the presence of the condition with the number of similarities indicating the probability of the condition. For example, particular genes for use in identifying pancreatic cancer are disclosed.
Owner:BAUER A ROBERT

Method for the early detection of breast cancer, lung cancer, pancreatic cancer and colon polyps, growths and cancers as well as other gastrointestinal disease conditions and the preoperative and postoperative monitoring of transplanted organs from the donor and in the recipient and their associated conditions related and unrelated to the organ transplantation

A method for the early diagnosis of breast, lung, pancreatic and colon growths and cancers as well as conditions associated with donor and recipient organ transplants, both before and after transplantation to identify and allow treatment of possible transplanted organ rejection and other disease conditions related and unrelated to the transplantation, compares the gene expression patterns from a patient's peripheral blood monocytes-lymphocyte's gene system with either the similar gene expression patterns of a normal person, or with the similar gene expression patterns of a person known to have the condition being screened for. Differences between the patient's gene expression patterns for particular genes and the normal patterns indicates the presence of the condition with the number of differences indicating the probability of the condition. Similarities between the patient's gene expression patterns for those particular genes and the patterns of a person known to have the condition indicates the presence of the condition with the number of similarities indicating the probability of the condition. For example, particular genes for use in identifying pancreatic cancer are disclosed.
Owner:BAUER A ROBERT

Method for diagnosing colon tumor via bacterial metagenomic analysis

The present invention relates to a method for predicting the incidence of a colon tumor, such as a colon polyp and colon cancer, and a causative factor thereof through metagenomic analysis of a bacterium-derived vesicle present in a human body-derived substance. More particularly, the present invention relates to a method for diagnosing a causative factor of a colon tumor and the risk of the incidence thereof by sequencing a metagenome present in a bacterium-derived vesicle present in excrement or urine. There are trillions of bacteria in an intestine, and the bacteria secrete vesicles out ofthe cells thereof for the purpose of information exchange. The bacteria are not absorbed into epithelial cells in a colon, but the vesicles secreted therefrom pass through the mucous membrane, are absorbed into the colonic epithelial cells, are distributed throughout the body via blood, and then are excreted through a liver and a kidney. The bacteria-derived vesicles may increase or decrease the occurrence of inflammation and cancer, and the present invention can be useful as a method for diagnosing the risk of the incidence of a colon tumor or a causative factor thereof by sequencing a genetic metagenome of a bacterium-derived vesicle present in a human body-derived substance. Further, an early diagnosis can still be made even after the incidence of a colon polyp or the onset of colon cancer, and the incidence of colon cancer can be lowered, and the treatment effect can be enhanced.
Owner:MD HEALTHCARE INC

Compositions and methods for treating inflammatory bowel disease and fusobacteria-caused or related diseases and conditions

Provided herein are pharmaceutical compositions, therapeutic combinations, devices and methods for treating, ameliorating, reversing, causing the remission of, and / or preventing (acting as a prophylaxis, or preventing the initiation of) an inflammatory bowel disorder (IBD) or inflammatory bowel disease (IBD), Ulcerative Colitis; Crohn's disease; J-pouch; fistulising Crohn's disease; a Colitis which can be microscopic, lymphocytic or collagenous; an eosinophilic colitis; indeterminate colitis; idiopathic colitis; diverticulosis and diverticulitis; relapsing diverticulitis; constipation associated inflammatory bowel disease and / or small intestinal bacterial overgrowth; Irritable Bowel Syndrome (IBS) with or without diarrhoea, constipation or pain predominant IBS; periodontitis; rheumatoid arthritis; respiratory infections, appendicitis, vascular disorders such as thrombophlebitis; bacteremia; osteomyelitis; septic shock; Alzheimer's disease; Lemierre syndrome (postanginal sepsis); colonic polyps or adenomas (optionally hyperplastic, adenomatous or serrated adenomas) or preventing the growth of colonic polyps or adenomas, bowl cancer, or metastases (optionally preventing the initiation or promotion of bowl cancer or metastasis); pharyngitis; otitis; sinusitis; and any disease, symptom or condition caused or exacerbated by a Fusobacteria (optionally, a F. nucleatum or F. varium) infection. In alternative embodiments, pharmaceutical compositions comprise rifaximin alone or in combination with other antibiotics or drugs.
Owner:托马斯·朱利叶斯·波洛迪

Traditional Chinese medicine composition for treating intestinal polyps

The invention provides a traditional Chinese medicine composition for treating intestinal polyps. The traditional Chinese medicine composition is prepared from, by weight, 5-10 parts of nodus nelumbinis rhizomatis, 5-10 parts of fructus mume, 5-15 parts of bombyx batryticatus, 1-5 parts of alumen, 1-5 parts of dried alum, 5-10 parts of bile, 20-40 parts of fructus mume preparata, 2-10 parts of rhizoma coptidis, 6-15 parts of stir-baked amur cork tree bark, 3-10 parts of aconitum carmichaeli debx, 2-10 parts of baked ginger, 3-12 parts of ramulus cinnamomi, 2-10 parts of herbal asari, 2-10 parts of dried peel of zanthoxylum schinifolium or zanthoxylum bungea, 3-15 parts of stir-baked radix codonopsis, 9-15 parts of radix angelica sinensis, 9-30 parts of rhizoma curcumae, 3-12 parts of stir-baked squama manitis, 9-15 parts of radix aucklandiae, 9-15 parts of semen arecae and 20-50 parts of all-grass of patrinia scabiosaefolia. The traditional Chinese medicine composition can be used for preparing medicine for treating colon polyps and rectal polyps and has the advantages of removing slough and promoting growth of tissue regeneration, cooling blood, stopping bleeding, stopping pain, taking effect quickly and being capable of achieving radical treatment and the like.
Owner:刘黎明

Compositions and methods for treating inflammatory bowel disease and fusobacteria-caused or related diseases and conditions

Provided herein are pharmaceutical compositions, therapeutic combinations, devices and methods for treating, ameliorating, reversing, causing the remission of, and/or preventing (acting as a prophylaxis, or preventing the initiation of) an inflammatory bowel disorder (IBD) or inflammatory bowel disease (IBD), Ulcerative Colitis; Crohn's disease; J-pouch; fistulising Crohn's disease; a Colitis which can be microscopic, lymphocytic or collagenous; an eosinophilic colitis; indeterminate colitis; idiopathic colitis; diverticulosis and diverticulitis; relapsing diverticulitis; constipation associated inflammatory bowel disease and/or small intestinal bacterial overgrowth; Irritable Bowel Syndrome (IBS) with or without diarrhoea, constipation or pain predominant IBS; periodontitis; rheumatoid arthritis; respiratory infections, appendicitis, vascular disorders such as thrombophlebitis; bacteremia; osteomyelitis; septic shock; Alzheimer's disease; Lemierre syndrome (postanginal sepsis); colonic polyps or adenomas (optionally hyperplastic, adenomatous or serrated adenomas) or preventing the growth of colonic polyps or adenomas, bowl cancer, or metastases (optionally preventing the initiation or promotion of bowl cancer or metastasis); pharyngitis; otitis; sinusitis; and any disease, symptom or condition caused or exacerbated by a Fusobacteria (optionally, a F. nucleatum or F. varium) infection. In alternative embodiments, pharmaceutical compositions comprise rifaximin alone or in combination with other antibiotics or drugs.
Owner:BORODY THOMAS JULIUS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products